{
  "id": 10130386,
  "title": "Medpace Holdings CEO August Troendle sells $44.4m stock",
  "url": "https://urgent.news/2026/09/27/medpace-holdings-ceo-august-troendle-sells-44-4m-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-27T04:01:07.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/medpace-holdings-ceo-august-troendle-sells-444m-stock-93CH-4918784"
  },
  "original_language": "en",
  "account": "August J. Troendle, CEO of Medpace Holdings Inc., sold a substantial amount of the company's stock in September 2026. In two separate transactions, he sold 70,901 shares, valued at roughly $44.4 million. The share price ranged between $620.00 and $632.815 at the time of sale. Despite this insider sale, Medpace Holdings has been actively buying back shares. The company reported strong second-quarter 2026 results, exceeding Wall Street's expectations with increased revenue and earnings per share. Following these sales, Mr. Troendle still holds over 400,000 shares of Medpace Holdings, including indirect ownership through his LLC. The company's management remains optimistic about its future performance.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "OnKure Therapeutics CFO Jason Leverone sells $898 in stock",
        "url": "https://urgent.news/2026/09/27/onkure-therapeutics-cfo-jason-leverone-sells-898-in-stock",
        "published": "2026-09-27T01:31:05.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}